CRISPR/Cas9-Mediated Genome Editing to Generate Clonal iPSC Lines

Carla Sanjurjo-Soriano1,2, Nejla Erkilic1,2, Daria Mamaeva1,2

  • 1Institute for Neurosciences of Montpellier, Inserm, Montpellier, France.

Summary

This study presents an efficient method for genetically engineering human induced pluripotent stem cells (hiPSCs) using CRISPR/Cas9 technology. The described protocol simplifies the process, enabling direct use of edited hiPSC lines for various applications.